Log In
BCIQ
Print this Print this
 

Fluzone QIV (Fluzone Intradermal Quadrivalent)

Also known as: Fluzone Quadrivalent

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionInactivated quadrivalent influenza vaccine containing 2 strains of type A (H1N1 and H3N2) and 2 strains of type B (1 each from Yamagata and Victoria lineages) influenza
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsVaccinate against seasonal influenza virus in children ages 6 months to 8 years; Vaccinate against seasonal influenza virus in adults ages 18 and up; Vaccinate against seasonal influenza virus in adults ages 65 and up
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today